To further assess the clinical values of NUF2, CDCA3, and KIF14 in ccRCC patients, we performed combined survival analysis and ROC analysis of METTL14 and these three m6A-modified genes, respectively. The gene discussed is CDCA3; the disease is nonpapillary renal cell carcinoma.